Overview

Molecular Imaging of Plaque Vulnerability

Status:
Unknown status

Trial end date:
2020-03-01

Target enrollment:

Participant gender:

Summary

Accumulating data in the literature suggests that radiolabeled-choline (18F-choline) is a sensitive molecular tracer for PET imaging that is taken up in activated cells and, as such, is able to identify active inflammatory sites. The investigators hypothesize that 18F-choline is also highly taken up in vulnerable plaques in comparison to the stable ones.

Phase:

Phase 3

Details

Lead Sponsor:

Maastricht University Medical Center

Collaborator:

Center for Translational Molecular Medicine

Treatments:

Choline